Literature DB >> 20233277

Is one question enough to detect female sexual dysfunctions? A diagnostic accuracy study in 6,194 women.

Levente Kriston1, Cindy Günzler, Anke Rohde, Michael M Berner.   

Abstract

INTRODUCTION: Literature shows that recognition of sexual dysfunctions in women is insufficient and existing instruments to aid detection are mostly too extensive to be used in routine practice. AIM: To develop a brief and accurate screening instrument to detect female sexual dysfunctions in routine care.
METHODS: The initial item pool for the index test consisted of 15 items. In a 4-year period, a total of 12,957 persons filled out the test on a specifically designed web-site. Six thousand one hundred ninety-four complete data sets could be used for statistical analysis. The validated German version of the Female Sexual Function Index (FSFI-d) served as reference standard to estimate the accuracy of the screening test. In order to test several possible ways of combining items a multi-step procedure employing univariate analyses, multiple logistic regression, and classification and regression tree analysis was applied to a learning sample and cross-validated in a test sample. MAIN OUTCOME MEASURES: Diagnostic performance (sensitivity, specificity, positive and negative predictive value, accuracy, diagnostic odds ratio as well as adjusted odds ratio) of the items and resulting models to discriminate women with sexual dysfunction from those without were calculated.
RESULTS: One dichotomous question for overall satisfaction proved to show high accuracy as a stand-alone instrument and played also a central role in multivariate models. It may be recommended as a one-question screening test (76.4% sensitivity and 76.5% specificity in the test sample). A hierarchical two-question test yielded higher sensitivity (93.5%) and lower specificity (60.1%). A slightly more extensive version consists of five questions (83.1% sensitivity and 81.2% specificity).
CONCLUSIONS: Despite some methodological limitations of our study all developed tests showed acceptable to good diagnostic performance, all are very short and could therefore be easily implemented into routine care. Further tests of psychometric properties in other settings are needed.

Entities:  

Mesh:

Year:  2010        PMID: 20233277     DOI: 10.1111/j.1743-6109.2010.01729.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  Translation and validation of the Greek version of the female sexual function index questionnaire.

Authors:  A Zachariou; M Filiponi; P S Kirana
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

2.  Insufficient diagnostic accuracy of a single-item questionnaire to detect psychosocial distress in temporomandibular disorder patients.

Authors:  Daniel R Reissmann; Mike T John; Levente Kriston; Oliver Schierz
Journal:  Clin Oral Investig       Date:  2012-12-06       Impact factor: 3.573

3.  Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction.

Authors:  Stephanie C Knüpfer; Martina D Liechti; Livio Mordasini; Dominik Abt; Daniel S Engeler; Jens Wöllner; Jürgen Pannek; Bernhard Kiss; Fiona C Burkhard; Marc P Schneider; Elena Miramontes; Alfons G Kessels; Lucas M Bachmann; Thomas M Kessler
Journal:  BMC Urol       Date:  2014-08-13       Impact factor: 2.264

4.  Preliminary Validation of a German Version of the Sexual Complaints Screener for Women in a Female Population Sample.

Authors:  Andrea Burri; Hartmut Porst
Journal:  Sex Med       Date:  2018-02-17       Impact factor: 2.491

5.  Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis.

Authors:  Janet S Carpenter; Salene M W Jones; Christina R Studts; Julia R Heiman; Susan D Reed; Katherine M Newton; Katherine A Guthrie; Joseph C Larson; Lee S Cohen; Ellen W Freeman; R Jane Lau; Lee A Learman; Jan L Shifren
Journal:  Arch Sex Behav       Date:  2016-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.